While some of these truncations, such as NF1 in UCEC and MAP2K4 in BRCA, were often accompanied by lower-than-median mRNA expression in their respective tumor cohorts, their impacts were strikingly observed at diminished protein expression levels. The gene discussed is MAP2K4; the disease is neoplasm.